Product peptide-synthetic-peptide

Home > products > peptide> synthetic-peptide

Catalog	name	Description	price
R-M-1241	TRAP-5 trifluoroacetate salt,CAS:141685-53-2	The pentapeptide TRAP-5, SFLLR, is the minimal peptide length which retains full activity in releasing serotonin from human platelets.	price>
R-M-1242	TRAP-7 trifluoroacetate salt,CAS :145229-76-1	The thrombin receptor agonist TRAP-7, SFLLRNP, corresponds to residues 42-48 of the thrombin receptor. TRAP-7 is as effective as thrombin in inducing Ca²⁺mobilization and protein kinase C activation in some T cell lines.	price>
R-M-1244	(Ala¹¹·²²·²⁸)-VIP (human, mouse, rat) trifluoroacetate salt,CAS: 291524-04-4	Highly selective human VPAC1 receptor agonist. It showed a 1000-fold higher efficiency in stimulating adenylate cyclase activity from VPAC1 than from VPAC2 receptors and therefore represents an effective pharmacological tool to characterize VPAC1 receptor-mediated events.	price>
R-M-1246	(p-Chloro-D-Phe⁶,Leu¹⁷)-VIP (human, mouse, rat),CAS:02805-45-8	(p-Chloro-D-Phe⁶,Leu¹⁷)-VIP (human, mouse, rat) trifluoroacetate salt(CAS : 102805-45-8) is a Specific VIP receptor antagonist.	price>
R-M-1247	Myristoyl-(Lys¹²·²⁷·²⁸)-VIP-Gly-Gly-Thr (free acid) trifluoroacetate salt,CAS:2243219-86-3	PG 99-465 is a high affinity, selective VPAC2 receptor antagonist. It exhibited a 100-fold preference for the VPAC2 over the VPAC1 receptor. The compound showed partial agonistic activity on the VPAC1 receptor and was inactive on the VPAC2 receptor transfected in CHO cells, as well as on naturally expressed human VPAC2 receptors in the SUP T1 cell line. Dickson et al. observed an agonistic effect of PG99-465 on the human VPAC1 and PAC1 receptors. When applied singly, PG99-465 increased [cAMP](i) at all three hVPAC/PAC receptor subtypes.	price>
R-M-1248	VIP (6-28) (human, mouse, rat) trifluoroacetate salt,CAS :69698-54-0	VIP (6-28) (human, mouse, rat) trifluoroacetate salt,CAS :69698-54-0 fromruixi.This carboxy-terminal VIP fragment was found to be twofold more potent than any previously described VIP receptor antagonists.	price>
R-M-1249	Prepro-von Willebrand factor (641-650) (bovine) trifluoroacetate salt,CAS:143470-36-4	Prepro-von Willebrand factor (641-650) (bovine) trifluoroacetate salt,CAS:143470-36-4 from ruixi.The decapeptide WREPSFCALS (derived from von Willebrand factor) shows increased affinity for collagen and enhances wound healing.	price>
R-M-1250	WRW4 trifluoroacetate salt,CAS: 878557-55-2	Antagonist of formyl peptide receptor-like 1 (FPRL1) signalling. WRW4 inhibits WKYMVm binding to FPRL1 (IC₅₀ 0.23 mM) as well as the intracellular calcium release induced by WKYMVm, MMK-1, amyloid β42, and F peptide. The tryptophan-rich peptide also inhibits FPRL1-mediated signalling in human neutrophils and blocks chemotactic migration and superoxide generation by Aβ42. WRW4 inhibited the activation of FPRL2 by F2L, an FPRL2-selective endogenous agonist, resulting in the complete inhibition of intracellular calcium increase and chemotactic migration.	price>
R-M-1252	Xenopsin (XP),CAS :51827-01-1	The octapeptide xenopsin is found in relatively high amounts in skin extracts from the South African frog Xenopus laevis. It shows sequence homology to mammalian neurotensin and shares a number of its biological properties.	price>
R-M-1253	Xenopsin-Related Peptide 2 (XP-2) trifluoroacetate salt,CAS:117442-29-2	Xenopsin-Related Peptide 2 (XP-2) trifluoroacetate salt,CAS:117442-29-2 from ruixi.This peptide from avian gastric extracts has a strong resemblance to xenopsin and shows similar biological effects.	price>

...